Expression of fibroblast growth factors in human non-papillary renal cell carcinoma: Correlation with tumor progression
โ Scribed by K. Yamanaka; Hideaki Miyake; Isao Hara; Kazuo Gohji; Soichi Arakawa; Sadao Kamidono
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 86 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1341-9625
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Vascular endothelial growth factor (VEGF) functions as a regulator of neovascularization in malignant cells. VEGF as a mitogen is thought to alter renal cell carcinoma formation and tumor progression. We investigated the expression of the VEGF gene in order to evaluate its clinical sign
## BACKGROUND. Recent reports have shown altered expression of CD44 in renal cell carcinomas. However, to the authors' knowledge there are no data correlating CD44 expression in renal cell carcinomas with subsequent tumor progression or recurrence, nor is there information about the presence of pa
Hepatocyte growth factor/scatter factor (HGF/SF) induces cell motility and tissue remodeling of various epithelial cells through its receptor, the product of the proto-oncogene c-met. High levels of HGF/SF have been correlated with poor prognosis in human breast carcinoma. In this study, we examined
## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the